for a standing committee, perhaps at the level of the Scientific Advisor 
to the President. 
The Energy Research and Development Administration (ERDA) reported that 
instructions had been sent to all associated laboratories that the NIH 
guidelines are to govern recombinant DNA research. Because most research 
supported by ERDA is done in facilities run by ERDA, strict surveillance 
is possible. ERDA suggested, for purposes of management, that research 
proposals perhaps could be forwarded to an NIH study secrion for a 
scientific and biohazard review. ERDA, however, would retain the right 
of final approval or disapproval after that review. At present, there 
is currently no recombinant DNA research in progress or being planned 
but there are a number of scientists working in related areas. 
The National Aeronautics and Space Administration (NASA) reported that 
there is no current or planned recombinant DNA research activity. 
The National Science Foundation (NSF) has accepted the NIH guidelines 
and is currently reviewing mechanisms for implementation. For example, 
NSF is considering the creation of its own appellate mechanism concerning 
questions over standards, practices, and procedures, as outlined in the 
guidelines. NSF currently has awarded 52 research projects that involve 
at least in part recombinant DNA research. Twenty more projects are 
pending. Of those awarded, 6 require physical containment at the 
third level (moderate potential risk). The total amount for the 52 
awarded projects is $3.3 million, but as noted, recombinant DNA research 
activities comprised an undetermined fraction of this total. 
( 235 ) 
